Non-coding variants upstream of MEF2C cause severe developmental disorder through three distinct loss-of-function mechanisms

Caroline F Wright, Nicholas M Quaife, Laura Ramos-Hernández, Petr Danecek, Matteo P Ferla, Kaitlin E Samocha, Joanna Kaplanis, Eugene J Gardner, Ruth Y Eberhardt, Katherine R Chao, Konrad J Karczewski, Joannella Morales, Meena Balasubramanian, Siddharth Banka, Lianne Gompertz, Bronwyn Kerr, Amelia Kirby, Sally A Lynch, Jenny EV Morton, Hailey Pinz, Francis H Sansbury, Helen Stewart, Britton D Zuccarelli, Genomics England Research Consortium, Stuart A Cook, Jenny C Taylor, Jane Juusola, Kyle Retterer, Helen V Firth, Matthew E Hurles, Enrique Lara-Pezzi, Paul JR Barton, Nicola Whiffin
doi: https://doi.org/10.1101/2020.11.15.20229807

Article Information

doi 
https://doi.org/10.1101/2020.11.15.20229807
History 
  • November 16, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Caroline F Wright1,
  2. Nicholas M Quaife2,3,
  3. Laura Ramos-Hernández4,
  4. Petr Danecek5,
  5. Matteo P Ferla6,
  6. Kaitlin E Samocha5,
  7. Joanna Kaplanis5,
  8. Eugene J Gardner5,
  9. Ruth Y Eberhardt5,
  10. Katherine R Chao7,8,
  11. Konrad J Karczewski7,8,
  12. Joannella Morales9,
  13. Meena Balasubramanian10,11,
  14. Siddharth Banka12,13,
  15. Lianne Gompertz12,
  16. Bronwyn Kerr13,
  17. Amelia Kirby14,
  18. Sally A Lynch15,
  19. Jenny EV Morton16,
  20. Hailey Pinz17,
  21. Francis H Sansbury18,
  22. Helen Stewart19,
  23. Britton D Zuccarelli20,
  24. Genomics England Research Consortium,
  25. Stuart A Cook2,
  26. Jenny C Taylor6,
  27. Jane Juusola21,
  28. Kyle Retterer21,
  29. Helen V Firth5,22,
  30. Matthew E Hurles5,
  31. Enrique Lara-Pezzi4,23,
  32. Paul JR Barton2,3 and
  33. Nicola Whiffin5,8,24,*
  1. 1Institute of Biomedical and Clinical Science, University of Exeter Medical School, Royal Devon & Exeter Hospital, Exeter, UK
  2. 2National Heart & Lung Institute and MRC London Institute of Medical Sciences, Imperial College London, London, UK
  3. 3Cardiovascular Research Centre, Royal Brompton & Harefield Hospitals NHS Trust, London, UK
  4. 4Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain
  5. 5Human Genetics Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
  6. 6National Institute for Health Research Oxford Biomedical Research Centre, Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK
  7. 7Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA
  8. 8Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
  9. 9European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK
  10. 10Sheffield Clinical Genetics Service, Sheffield Children’s NHS Foundation Trust, Sheffield, UK
  11. 11Academic Unit of Child Health, Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK
  12. 12Manchester Centre for Genomic Medicine, St Mary’s Hospital, Manchester University Hospitals NHS Foundation Trust, Health Innovation Manchester, Manchester, UK
  13. 13Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Oxford Road, Manchester, UK
  14. 14Department of Pediatrics, Wake Forest School of Medicine, Winston-Salem, NC, USA
  15. 15UCD Academic Centre on Rare Diseases, School of Medicine and Medical Sciences, University College Dublin, and Clinical Genetics, Temple Street Children’s University Hospital, Dublin, Ireland
  16. 16West Midlands Regional Clinical Genetics Service and Birmingham Health Partners, Birmingham Women’s and Children’s Hospitals NHS Foundation Trust, Birmingham, UK
  17. 17Department of Pediatrics, Saint Louis University School of Medicine, Saint Louis, MO, USA
  18. 18All Wales Medical Genomics Service, NHS Wales Cardiff and Vale University Health Board, Institute of Medical Genetics, University Hospital of Wales, Cardiff, UK
  19. 19Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
  20. 20Department of Neurology, University of Kansas School of Medicine-Salina Campus, Salina, KS, US
  21. 21GeneDx, Gaithersburg, MD, USA
  22. 22East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
  23. 23CIBER de enfermedades CardioVasculares (CIBERCV), Spain
  24. 24Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK
  1. ↵*Correspondence should be addressed to nwhiffin{at}well.ox.ac.uk
Back to top
Posted November 16, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Non-coding variants upstream of MEF2C cause severe developmental disorder through three distinct loss-of-function mechanisms
Caroline F Wright, Nicholas M Quaife, Laura Ramos-Hernández, Petr Danecek, Matteo P Ferla, Kaitlin E Samocha, Joanna Kaplanis, Eugene J Gardner, Ruth Y Eberhardt, Katherine R Chao, Konrad J Karczewski, Joannella Morales, Meena Balasubramanian, Siddharth Banka, Lianne Gompertz, Bronwyn Kerr, Amelia Kirby, Sally A Lynch, Jenny EV Morton, Hailey Pinz, Francis H Sansbury, Helen Stewart, Britton D Zuccarelli, Genomics England Research Consortium, Stuart A Cook, Jenny C Taylor, Jane Juusola, Kyle Retterer, Helen V Firth, Matthew E Hurles, Enrique Lara-Pezzi, Paul JR Barton, Nicola Whiffin
medRxiv 2020.11.15.20229807; doi: https://doi.org/10.1101/2020.11.15.20229807
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area